Safety Alerts

MHRA Class 4 Medicines Defect Notification: Hiprex 1g tablets (Doncaster Pharma Ltd)

Published
Source
PSNC Dispensing & Supply News
Imported
6 Jun 2026

MHRA Class 4 Medicines Defect Notification: Hiprex 1g tablets (Doncaster Pharma Limited) Drug alert number: EL(26)A/20 Date issued: 22 April 2026 Doncaster Pharma Limited has informed the MHRA of an error related to the Braille embossing on the outer packaging of the above mentioned parallel imported batches of Hiprex 1 g tablets (POM). It was identified [...]

The post MHRA Class 4 Medicines Defect Notification: Hiprex 1g tablets (Doncaster Pharma Ltd) appeared first on Community Pharmacy England.

View original alert (opens in a new tab)

Important: This alert is gathered automatically for information only. Always refer to the original source and follow your practice’s own clinical governance procedures.

The weekly digest lists every alert published in a week, grouped by source. View the weekly digest

Back to Safety Alerts